Chesdachai, Supavit
Rivera, Christina G.
Cole, Kristin C.
Teaford, Hilary R.
Gonzalez Suarez, Maria L.
Larsen, Jennifer J.
Ganesh, Ravindra
Tulledge-Scheitel, Sidna
Razonable, Raymund R.
Article History
Received: 27 November 2023
Accepted: 4 March 2024
First Online: 5 March 2024
Competing interests
: RRR received research funds from Gilead, Regeneron and Roche on projects not directly related to this study, as member of the DSMB for Novartis, as member of the Endpoint Adjudication Committee for Allovir, and is on the American Society of Transplantation Board of Directors. RRR is also member of the Awards Committee and Inclusion, Diversity, Access and Equity Committee of the Infectious Diseases Society of America and Editor of Transplant Infectious Diseases. CGR has served as member of advisory board for Gilead Inc. Others declare no conflict of interest.